Cargando…
ANXA3/JNK Signaling Promotes Self-Renewal and Tumor Growth, and Its Blockade Provides a Therapeutic Target for Hepatocellular Carcinoma
Frequent tumor relapse in hepatocellular carcinoma (HCC) has been commonly attributed to the presence of residual cancer stem cells (CSCs) after conventional treatments. We have previously identified and characterized CD133 to mark a specific CSC subset in HCC. In the present study, we found endogen...
Autores principales: | Tong, Man, Fung, Tsun-Ming, Luk, Steve T., Ng, Kai-Yu, Lee, Terence K., Lin, Chi-Ho, Yam, Judy W., Chan, Kwok Wah, Ng, Fai, Zheng, Bo-Jian, Yuan, Yun-Fei, Xie, Dan, Lo, Chung-Mau, Man, Kwan, Guan, Xin-Yuan, Ma, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4618447/ https://www.ncbi.nlm.nih.gov/pubmed/26095609 http://dx.doi.org/10.1016/j.stemcr.2015.05.013 |
Ejemplares similares
-
Chemotherapy‐Enriched THBS2‐Deficient Cancer Stem Cells Drive Hepatocarcinogenesis through Matrix Softness Induced Histone H3 Modifications
por: Ng, Kai‐Yu, et al.
Publicado: (2021) -
ANXA3 Silencing Ameliorates Intracranial Aneurysm via Inhibition of the JNK Signaling Pathway
por: Wang, Yang, et al.
Publicado: (2019) -
Retraction Notice to: ANXA3 Silencing Ameliorates Intracranial Aneurysm via Inhibition of the JNK Signaling Pathway
por: Wang, Yang, et al.
Publicado: (2022) -
Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133
por: Chai, Stella, et al.
Publicado: (2014) -
Transcriptome Analysis of Acute Phase Liver Graft Injury in Liver Transplantation
por: Lee, Nikki P., et al.
Publicado: (2018)